Zdrowie i gospodarka · 17/08/2009
FDA Clears Way for Torsemide Injection to be Sold
The FDA has determined that DEMADEX (torsemide) injection, 20 mg/2mL and 50 mg/5mL, was not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of generic versions.
Source: Federal Register — Food and Drug AdministrationOpen original release →